ORMP Oramed Pharmaceuticals Inc.
Healthcare$4.04+0.00%OpenMarket Cap: $165.3M
As of 2026-05-26
Valuation
P/E (TTM)
1.89
PEG
0.00
P/B
0.68
P/S
0.00
EV/EBITDA
2.22
DCF Value
$1.18
FCF Yield
-7.8%
Div Yield
6.3%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
61.0%
ROA
60.4%
ROIC
-5.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | NaN% | $0.00 | $38.3M | $— | $0.25 |
| Q4 null | $0.00 | NaN% | $-5.7M | $10.0M | $— | — |
| FY null | $2.0M | 0.7% | $-15.1M | $64.0M | $— | — |
| Q3 null | $0.00 | -Infinity% | $-2.4M | $48.4M | $— | — |
| Q2 null | $0.00 | NaN% | $-2.5M | $13.3M | $— | — |
| Q1 null | $2.0M | 0.7% | $-4.5M | $-7.6M | $— | — |
| Q4 null | $0.00 | -Infinity% | $-3.6M | $-10.2M | $— | — |
| FY null | $0.00 | -Infinity% | $-12.8M | $-19.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-3.1M | $-19.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-3.1M | $9.2M | $— | — |
| Q1 null | $0.00 | NaN% | $-3.0M | $1.5M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-3.9M | $13.3M | $0.33 | — |